Trellus Health signs two contracts with Mount Sinai

The AIM-traded firm said the first contract would see Mount Sinai make the Trellus IBD programme available to, and paid for, as a wellness benefit to all employees, focusing initially on inflammatory bowel disease (IBD), including Crohn's disease, and ulcerative colitis.

It said Mount Sinai had a “robust” employee wellness program offered free-of-charge to all faculty and staff.

The second contract would make the Trellus IBD program available to eligible patients, again as a wellness benefit, who are members of a large New York state labour union which provides health services and benefits to its members through Mount Sinai.

Trellis said the contracts supported its strategy of accessing patients to expand the rollout of its solution.

“As announced in our recent half-year report, Trellus has been making significant progress in advancing our business-to-business-to-consumer strategy, and I am delighted that we have signed these contracts with such a prestigious partner as Mount Sinai,” said chief executive officer Dr Marla Dubinsky.

“We believe that these contracts reflect the importance of our solution to healthcare providers and employers who want to empower their patients and employees to master the art of self-management, manage their chronic conditions with confidence, and improve health outcomes at a significantly lower cost.”

Dr Dubinsky said Trellus represented “a paradigm shift” in the way patients with chronic health conditions were supported, incorporating a whole-person methodology that to-date had been “missing” from the “collective” approach.

“These contracts with Mount Sinai will support our commercial goals of adding more patient members to the Trellus programmes through increased access.”

At 1118 BST, shares in Trellus Health were up 5.56% at 14.25p.

Reporting by Josh White at Sharecast.com.